• Arise from neuroendocrine cells throughout the gut and produce endocrine and vasocative substances
• Metastases more likely in tumors > 2 cm
• Most are small and asymptomatic
• Hepatic metastases produce the carcinoid syndrome—cutaneous flushing, diarrhea, bronchoconstriction
• Resection of primary and isolated hepatic metastases indicated for cure or palliation
• Arise from gut enterochromaffin cells
• Part of amine precursor uptake decarboxylase (APUD) system: Describes related neuroendocrine cells
• Midgut carcinoids produce serotonin, substance P, neuromedin A, bradykinin, dopamine, and histamine
• 85% of GI carcinoid tumors are in the appendix; 15% are in the small intestine, 90% of which are in the ileum
• Multiple synchronous tumors are present in 40% of cases
• At the time of surgical diagnosis, 40% of tumors have invaded the muscularis and 45% have metastasized to lymph nodes or liver
• 20% of patients have a second noncarcinoid tumor—breast, lung, and colon
• Mesenteric desmoplastic reaction and mesenteric vascular sclerosis is thought to be secondary to serotonin secretion and results in obstruction, bowel ischemia, and obstruction
• Biologically active substances secreted by carcinoids are usually inactivated in the liver, but hepatic metastases or primary ovarian or bronchial carcinoids release these compounds directly into the systemic circulation, where they produce symptoms
• Chemotherapy (streptozocin, 5-fluorouracil, doxorubicin) may be beneficial for metastatic disease if progressive
• Octreotide and histamine antagonists for carcinoid syndrome
• Intestinal ischemia
• Carcinoid syndrome
• 70% overall 5-year survival rate
• 14-year median survival from time of diagnosis
• 8-year median survival from onset of the carcinoid ...
Log In to View More
If you don't have a subscription, please view our individual subscription options below to find out how you can gain access to this content.
Want remote access to your institution's subscription?
Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.
If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
AccessSurgery Full Site: One-Year Subscription
Connect to the full suite of AccessSurgery content and resources including more than 160 instructional videos, 16,000+ high-quality images, interactive board review, 20+ textbooks, and more.
Pay Per View: Timed Access to all of AccessSurgery
24 Hour Subscription $34.95
48 Hour Subscription $54.95
Pop-up div Successfully Displayed
This div only appears when the trigger link is hovered over.
Otherwise it is hidden from view.